KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOA Surface Area (m2) Blood priming Volume (ml) Clearances at QB 200/300 (ml/min) UF Coefficient (Ultrafiltration)(ml/mmHg.h) Type
Inulin Vitamine B12 Phosphate Creatinine Urea
778 1.0 32 72/78 105/118 156/186 168/205 184/246 6.8 PS 100 HF
836 1.3 43 86/95 120/135 170/205 175/221 189/251 8.8 PS 130 HF
1145 1.6 55 108/120 142/165 183/233 191/252 195/270 12.9 PS 160 HF
1265 1.8 59 116/131 149/176 187/242 193/260 196/275 15.5 PS 180 HF
916 1.0 54 99/107 136/156 177/221 186/241 191/257 8.4 PES 130 HF
1167 1.3 62 111/124 148/172 184/237 191/254 194/271 10.4 PES 160 HF
1321 1.6 78 118/133 153/180 179/245 195/263 198/277 12.1 PES 180 HF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation Sharpened sieving profile (S.E.T) Optimized dialysate side distribution Higher mechanical strength resulting in Low albumin loss High middle molecule removal Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal